Skip to main content
Equibles

Legal & General Group Plc

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 764068 London, X0
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,696
+$32,305 QoQ
Shares Held
7,858
+1167.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 89 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. XFOR ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in XFOR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,696 7,858
2025-03-31 $4,391 18,609
2024-12-31 $13,659 18,609
2024-09-30 $12,449 18,609
2024-06-30 $10,793 18,609
2024-03-31 $15,743 11,326
2023-12-31 $9,502 11,326
2023-09-30 $12,345 11,326
2023-06-30 $25,995 13,400
2021-03-31 $12,252 1,423
2020-12-31 $9,149 1,423
2020-09-30 $9,633 1,423
2020-06-30 $17,344 1,861
2020-03-31 $23,719 2,372